MYCOPHENOLATEMOFETIL 360MG

Myfortic 360mg is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Myfortic 360mg should be used concomitantly with cyclosporine and corticosteroids.

Mycophenolate Mofetil

Myfortic

360mg

10 Tablets in 1 strip




DESCRIPTION

Myfortic 360mg (inactive form) is a prodrug of Mycophenolic acid (MPA) and it is an immunosuppressive drug. Following oral administration, mycophenolate mofetil is fastly absorbed and hydrolysed (converted) to Mycophenolic acid.

Mycophenolic acid (MPA) is the active metabolite which has pharmacological activity.

Myfortic 360mg is a prescription drug provided under the supervision of doctors.

Mechanism of action

Myfortic is the 2-morpholinoethyl ester of MPA. MPA (Mycophenolic acid) is a potent, selective, uncompetitive and reversible prohibitor of inosine monophosphate dehydrogenase, and thereby prevents the de novo pathway of guanosine nucleotide development without fusion into DNA.
Because T- and B-lymphocytes are mortally weak for their replication on de novo synthesis of purines although another cell types can utilise salvage pathways, Mycophenolic acid has more potent cytostatic effects on lymphocytes than on other cells.



Pharmacokinetic

In oral administration, rapidly absorbed and bioavailability are 94% for oral Mycophenolate mofetil relative Mycophenolate mofetil intravenous.

The active metabolite MPA bounded to plasma protein is 98%.

Mainly metabolised by glucuronic transferase to form inactive phenolic glucuronide of MPA.

Myfortic 360mg is completely recovered with 93% dose in urine and 6% via feces and 87% administrated dose excreted via urine as MPAG.
Half-life of myfortic is 13-17 hours



Blueberrypharma.com-img1

mycophenolate-mofetil-360mg

Ingredients Mycophenolate Mofetil
Strength 360mg
Pack 10 Tablets in 1 strip
Rating

Myfortic is mainly required for preventions of organ transplant of kidney, heart and liver, the dosage as follows :
Kidney transplantation
For Adult the prescribed dose is 1 g given orally or intravenously (over no less than 2 hours) twice a day.
For paediatric (3 months to 18 years of age) the prescribed dose of the oral suspension is 600 mg/m2 given twice daily (maximum daily dose of 2 g/10 ml).
Dosage also calculated according to body surface area
Patients with a body surface area of 1.25 m2 to 1.5 m2 may be taken capsules at a dose of 750 mg twice daily.
Patients with a body surface area >1.5 m2 may be administrated with capsules or tablets at a 1 g dose twice daily.

Heart transplantation
For Adults the usual dose is 1.5 g given twice daily intravenously over no less than 2 hours or 1.5 g administrated orally twice daily.
Liver Transplantation
For Adults the prescribed dose is 1 g twice daily given via intravenously over no less than 2 hours or 1.5 g orally twice daily.
For Geriatrics (elderly patients) the prescribed orally is 1 g dose twice daily for renal transplant patients, 1.5 g dose given twice daily for heart transplant patients, and 1 g dose twice in a day administered intravenously or 1.5 g dose twice in a day administered orally in liver transplant patients.

Side effects

Common side effects :
Diarrhoea, Vomiting, Pain, Abdominal pain, Hypertension, Swelling of the ankles or feet, lower legs.

Serious side effects

Infection, Infection in blood, Pharyngitis, Low RBC, and WBC, thrombocytopenia

Precautions

Embryofoetal Toxicity :
Mofortic 180mg can leads risk to foetal when administered to a pregnant female. While Use of mofilet during pregnancy is along with an increased risk of first trimester pregnancy loss and have high risk of congenital malformations, Lymphoma and Malignancy
Patients administrating immunosuppressive drug containing combinations of drugs, involves Myfortic 180mg, as part of an immunosuppressive regimen have high risk of developing lymphomas and other malignancies, specifically effect the skin Pregnancy Exposure Prevention and Planning
Females of reproductive probably should be made aware of the high risk of first trimester pregnancy loss and congenital malformations and must be advise about pregnancy prevention and planning
Combination with Other Immunosuppressive Agents :
Myfortic 360mg has been given in co administration with the following agents in clinical trials: antithymocyte globulin(ATGAM®), OKT3 (Orthoclone OKT® 3), cyclosporine (Sandimmune®, Neoral®) and corticosteroids should be avoided.

DRUG – DRUG INTERACTION

  • When Myfortic 360mg combination with acyclovir or ganciclovir may causes increases blood levels myfortic and interacting drugs elimination through kidneys the drugs complete with each other
  • Myfortic 180mg Interaction with antacid may decrease MPA blood levels
  • Interaction with proton pump may decrease blood levels by binding in the intestine.
  • Myfortic 180mg combining with birth control pills may reduce the effectiveness of some oral contraceptives
  • Probenecid may cause an high in MPA blood levels by prohibiting its excretion through renal tubular secretion

Contraindications

Myfortic 360mg is contraindicated to the patients having with;
Hypersensitivity to mycophenolate mofetil
Allergic to polysorbate 80 (tween)
Pregnant women
Breastfeeding women




Pregnancy category D
Using of Myfortic 360mg during pregnancy will have increased risk of 1st trimester loss and risk of congenital malformations

Avoid using Myfortic 360mg during breast feeding to infants

Myfortic 360mg is stored at 25°C Dispense in a tight, light resistant container

If dose is missed, have it soon before next dose reaches or skip the dose and follow normal timing Please Consult with the doctor


Blueberrypharma.com-img2



Quick Contact




Prescription upload






PRESCRIPTION


Blueberrypharma.com , a fully licensed and regulated pharmacy medicine, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.

Blueberrypharma.com will not dispense any prescription medication without a valid prescription from a licensed physician.

If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.

The drug information provided in the Blueberrypharma.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.

Blueberrypharma.com requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from Blueberrypharma.com

At Blueberrypharma.com , a Caregiver can order prescription medicines on your behalf.